Evidence map›Paper›PMID 39637079›Full record

ArticlePloS one2024

DRSegNet: A cutting-edge approach to Diabetic Retinopathy segmentation and classification using parameter-aware Nature-Inspired optimization.

Sundreen Asad Kamal, Youtian Du, Majdi Khalid, Majed Farrash, Sahraoui Dhelim

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sundreen Asad KamalSchool of Electronics and Information Technology, Xi'an Jiaotong University, Xian, China.
Youtian DuSchool of Electronics and Information Technology, Xi'an Jiaotong University, Xian, China.
Majdi KhalidDepartment of Computer Science and Artificial Intelligence, College of Computing, Umm Al-Qura University, Makkah, Saudi Arabia.
Majed FarrashDepartment of Computer Science and Artificial Intelligence, College of Computing, Umm Al-Qura University, Makkah, Saudi Arabia.
Sahraoui DhelimDublin City University, Dublin, Ireland.ORCID 0000-0002-3620-1395

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a prominent reason of blindness globally, which is a diagnostically challenging disease owing to the intricate process of its development and the human eye's complexity, which consists of nearly forty connected components like the retina, iris, optic nerve, and so on. This study proposes a novel approach to the identification of DR employing methods such as synthetic data generation, K- Means Clustering-Based Binary Grey Wolf Optimizer (KCBGWO), and Fully Convolutional Encoder-Decoder Networks (FCEDN). This is achieved using Generative Adversarial Networks (GANs) to generate high-quality synthetic data and transfer learning for accurate feature extraction and classification, integrating these with Extreme Learning Machines (ELM). The substantial evaluation plan we have provided on the IDRiD dataset gives exceptional outcomes, where our proposed model gives 99.87% accuracy and 99.33% sensitivity, while its specificity is 99. 78%. This is why the outcomes of the presented study can be viewed as promising in terms of the further development of the proposed approach for DR diagnosis, as well as in creating a new reference point within the framework of medical image analysis and providing more effective and timely treatments.

Indexed as

Diabetic RetinopathyAlgorithmsHumansImage Processing, Computer-AssistedMachine LearningNeural Networks, ComputerRetina

Identifiers

PMID39637079
PMCPMC11620556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.